Pulse oximetry screening for critical congenital heart disease in the neonatal intensive care unit

Objective: Pulse oximetry screening (POS) is an effective tool to detect critical congenital heart disease (CCHD) in asymptomatic term infants, but its value in the neonatal intensive care unit (NICU) requires further clarification. Study design: A retrospective review of 1005 babies without previou...

Full description

Saved in:
Bibliographic Details
Published in:Journal of perinatology 2016, Vol.36 (1), p.52-56
Main Authors: Goetz, E M, Magnuson, K M, Eickhoff, J C, Porte, M A, Hokanson, J S
Format: Article
Language:English
Subjects:
692/499
Analysis
Care and treatment
Congenital heart defects
Diagnosis
Echocardiography
Female
Gestational Age
Health screening
Heart Defects, Congenital - diagnosis
Humans
Infant
Infant, Newborn
Intensive Care Units, Neonatal
Length of Stay - statistics & numerical data
Male
Medicine
Medicine & Public Health
Neonatal Screening - methods
Newborn infants
original-article
Oximetry
Patient monitoring equipment
Pediatric Surgery
Pediatrics
Retrospective Studies
Wisconsin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Pulse oximetry screening (POS) is an effective tool to detect critical congenital heart disease (CCHD) in asymptomatic term infants, but its value in the neonatal intensive care unit (NICU) requires further clarification. Study design: A retrospective review of 1005 babies without previously diagnosed CCHD admitted to a level III NICU was performed to assess the risk for missed CCHD and performance of POS. Result: Of the 1005 NICU patients, 812 had documented POS and none failed POS. In 812 patients, 547 had delayed POS because of the use of supplemental oxygen. In 259/812 patients, POS was delayed until the baby was >2 weeks old. CCHD was excluded by echocardiography, irrespective of POS, in 287/1005 patients. Conclusion: POS can be performed in the NICU with minimal adverse effects. However, in many NICU patients CCHD is confirmed or excluded before POS, and POS will frequently be performed after CCHD would have been expected to become symptomatic.
ISSN:0743-8346
1476-5543
DOI:10.1038/jp.2015.150